Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B G Johnson

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Neuropharmacology|August 1, 1995
Selective inhibition of forskolin-stimulated cyclic AMP formation in rat hippocampus by a novel mGluR agonist, 2R,4R-4-aminopyrrolidine-2,4- dicarboxylateD D Schoepp, B G Johnson, C R Salhoff, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
2,3'-disubstituted-2-(2'-carboxycyclopropyl)glycines as potent and selective antagonists of metabotropic glutamate receptorsI Collado, J Ezquerra, A Mazón, et al.
Neuroscience|February 12, 2000
Evaluation of the activity of a novel metabotropic glutamate receptor antagonist (+/-)-2-amino-2-(3-cis and trans-carboxycyclobutyl-3-(9-thioxanthyl)propionic acid) in the in vitro neonatal spinal cord and in an in vivo pain modelY Chen, G Bacon, E Sher, et al.
Neuropharmacology|July 29, 1998
LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptorsA E Kingston, P L Ornstein, R A Wright, et al.
Neuropharmacology|January 1, 1996
The novel metabotropic glutamate receptor agonist 2R,4R-APDC potentiates stimulation of phosphoinositide hydrolysis in the rat hippocampus by 3,5-dihydroxyphenylglycine: evidence for a synergistic interaction between group 1 and group 2 receptorsD D Schoepp, C R Salhoff, R A Wright, et al.
Neuropharmacology|September 6, 2002
Increased anxiety-related behavior in mice deficient for metabotropic glutamate 8 (mGlu8) receptorA-M Linden, B G Johnson, S C Peters, et al.
Brain Research. Molecular Brain Research|April 29, 1998
Group III human metabotropic glutamate receptors 4, 7 and 8: molecular cloning, functional expression, and comparison of pharmacological properties in RGT cellsS Wu, R A Wright, P K Rockey, et al.
Neuropharmacology|January 1, 1997
LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptorsD D Schoepp, B G Johnson, R A Wright, et al.
Journal of Medicinal Chemistry|October 1, 1993
3,4-Dimethyl-4-(3-hydroxyphenyl)piperidines: opioid antagonists with potent anorectant activityC H Mitch, J D Leander, L G Mendelsohn, et al.
Journal of Medicinal Chemistry|February 17, 1998
2-substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 2. Effects of aromatic substitution, pharmacological characterization, and bioavailabilityP L Ornstein, T J Bleisch, M B Arnold, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Neuropharmacology|August 1, 1995
Selective inhibition of forskolin-stimulated cyclic AMP formation in rat hippocampus by a novel mGluR agonist, 2R,4R-4-aminopyrrolidine-2,4- dicarboxylateD D Schoepp, B G Johnson, C R Salhoff, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
2,3'-disubstituted-2-(2'-carboxycyclopropyl)glycines as potent and selective antagonists of metabotropic glutamate receptorsI Collado, J Ezquerra, A Mazón, et al.
Neuroscience|February 12, 2000
Evaluation of the activity of a novel metabotropic glutamate receptor antagonist (+/-)-2-amino-2-(3-cis and trans-carboxycyclobutyl-3-(9-thioxanthyl)propionic acid) in the in vitro neonatal spinal cord and in an in vivo pain modelY Chen, G Bacon, E Sher, et al.
Neuropharmacology|July 29, 1998
LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptorsA E Kingston, P L Ornstein, R A Wright, et al.
Neuropharmacology|January 1, 1996
The novel metabotropic glutamate receptor agonist 2R,4R-APDC potentiates stimulation of phosphoinositide hydrolysis in the rat hippocampus by 3,5-dihydroxyphenylglycine: evidence for a synergistic interaction between group 1 and group 2 receptorsD D Schoepp, C R Salhoff, R A Wright, et al.
Neuropharmacology|September 6, 2002
Increased anxiety-related behavior in mice deficient for metabotropic glutamate 8 (mGlu8) receptorA-M Linden, B G Johnson, S C Peters, et al.
Brain Research. Molecular Brain Research|April 29, 1998
Group III human metabotropic glutamate receptors 4, 7 and 8: molecular cloning, functional expression, and comparison of pharmacological properties in RGT cellsS Wu, R A Wright, P K Rockey, et al.
Neuropharmacology|January 1, 1997
LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptorsD D Schoepp, B G Johnson, R A Wright, et al.
Journal of Medicinal Chemistry|October 1, 1993
3,4-Dimethyl-4-(3-hydroxyphenyl)piperidines: opioid antagonists with potent anorectant activityC H Mitch, J D Leander, L G Mendelsohn, et al.
Journal of Medicinal Chemistry|February 17, 1998
2-substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 2. Effects of aromatic substitution, pharmacological characterization, and bioavailabilityP L Ornstein, T J Bleisch, M B Arnold, et al.
Pageof 8